HE Youjuan, YU Qian. Efficiency evaluation of different doses of ropivacaine combined with fentanyl for labor analgesia[J]. Journal of Clinical Medicine in Practice, 2019, 23(15): 38-41, 44. DOI: 10.7619/jcmp.201915010
Citation: HE Youjuan, YU Qian. Efficiency evaluation of different doses of ropivacaine combined with fentanyl for labor analgesia[J]. Journal of Clinical Medicine in Practice, 2019, 23(15): 38-41, 44. DOI: 10.7619/jcmp.201915010

Efficiency evaluation of different doses of ropivacaine combined with fentanyl for labor analgesia

More Information
  • Received Date: May 12, 2019
  • Revised Date: June 29, 2019
  • Available Online: February 23, 2021
  • Published Date: August 14, 2019
  •   Objective  To explore the efficiency and safety of different doses of ropivacaine combined with fentanyl for labor analgesia.
      Methods  A total of 120 normal single birth primiparas were selected and randomly divided into low dose group (0.10% ropivacaine combined with fentanyl), medium dose group (0.15% ropivacaine combined with fentanyl) and high dose group (0.20% ropivacaine combined with fentanyl), with 40 cases in each group. Maternal analgesia, labor process, mode of delivery, neonatal Apgar score and adverse reactions were compared among the three groups.
      Results  At the time points of 60 min and 120 min after analgesia, cervix opening 3 to 4 cm and 7 to 8 cm, the scores of maternal visual analogue scale (VAS) in medium dose group and high dose group were significantly lower than those in low dose group (P < 0.05). In high dose group, there were 4 cases (13.33%) with motor block after analgesia, and there was no case with motor block during analgesia in the other two groups. The onset time of analgesia in medium dose group and high dose group was significantly shorter than that in low dose group (P < 0.05). There were no significant differences in time of labor stage, mode of delivery and neonatal Apgar score among the three groups (P>0.05). The incidence rates of adverse reactions in low dose group, medium dose group and high dose group were 2.50%, 5.00% and 20.00% respectively, and there were significant differences among the three groups (P < 0.05).
      Conclusion  The 0.15% ropivacaine combined with fentanyl has the best effect and higher safety in labor analgesia.
  • [1]
    曹莉园, 周盛萍, 龚云辉, 等. 分娩镇痛对初产妇产程的影响[J]. 实用妇产科杂志, 2017, 33(4): 50-55. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201704019.htm
    [2]
    张弛, 王治, 卫建峰, 等. 罗哌卡因联合舒芬太尼和罗哌卡因联合芬太尼在硬膜外分娩镇痛中的应用及对比研究[J]. 中国药物与临床, 2017, 17(3): 430-432. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC201703056.htm
    [3]
    Khanna A, Saxena R, Dutta A, et al. Comparison of ropivacaine with and without fentanyl vs bupivacaine with fentanyl for postoperative epidural analgesia in bilateral total knee replacement surgery[J]. Journal of Clinical Anesthesia, 2017, 37(5): 7-13. http://www.sciencedirect.com/science/article/pii/S0952818016306924
    [4]
    张洁, 李爱媛. 罗哌卡因及舒芬太尼不同硬膜外分娩镇痛方案对产后尿潴留的影响[J]. 中国现代医学杂志, 2017, 5(10): 76-79. doi: 10.3969/j.issn.1005-8982.2017.10.015
    [5]
    Matsota P K, Drachtidi K H, Batistaki C Z, et al. Patient controlled epidural analgesia with and without basal infusion using ropivacaine 0. 15% and fentanyl 2 γ/mL for labour analgesia: prospective comparative randomised trial[J]. Minerva Anestesiologica, 2018, 8(9): 15-17. http://www.ncbi.nlm.nih.gov/pubmed/29338142
    [6]
    Dacvs G F, Mpvm D D. Evaluation of age and American Society of Anesthesiologists(ASA)physical status as risk factors for perianesthetic morbidity and mortality in the cat[J]. Journal of Veterinary Emergency & Critical Care, 2010, 12(1): 9-15.
    [7]
    Hsu H C, Tan C D, Chang C W, et al. Evaluation of nasal patency by visual analogue scale/nasal obstruction symptom evaluation questionnaires and anterior active rhinomanometry after septoplasty: retrospective one‐year follow‐up cohort study[J]. Clinical Otolaryngology, 2017, 42(1): 18-19. doi: 10.1111/coa.12662
    [8]
    AlMetwalli, Roshdi R, Mowafi, et al. Isometric Force Dynamometer Is Superior to Bromage Score in Prediction of Patients′Ambulation After Spinal Anesthesia in Ambulatory Surgeries[J]. Anesthesia & Analgesia, 2013, 116(2): 312-316. http://europepmc.org/abstract/MED/23302964
    [9]
    陈先侠. 镇痛分娩的临床应用研究进展[J]. 中国妇幼保健, 2018, 33(3): 3-5. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201803079.htm
    [10]
    郭力, 陈旋, 胡燕, 等. 罗哌卡因用于连续臂丛神经阻滞的最低运动阻滞浓度分析[J]. 重庆医学, 2017, 46(29): 4142-4144. doi: 10.3969/j.issn.1671-8348.2017.29.033
    [11]
    王春, 张望平, 金丹. 低浓度罗哌卡因复合芬太尼硬膜外麻醉在乳癌手术中的临床应用[J]. 西部医学, 2018, 30(11): 49-52. https://www.cnki.com.cn/Article/CJFDTOTAL-XIBU201811012.htm
    [12]
    季小清. 不同浓度罗哌卡因复合芬太尼用于分娩镇痛效果及母婴结局比较[J]. 现代仪器与医疗, 2017, 23(3): 54-56. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYI201703023.htm
    [13]
    李瑞, 罗志锴, 杨丽珍. 不同浓度罗哌卡因复合舒芬太尼在硬膜外镇痛分娩中的效果评价[J]. 实用临床医药杂志, 2018, 22(23): 82-84. doi: 10.7619/jcmp.201823024
    [14]
    Tomi M, Nishimura T, Nakashima E. Mother-to-fetus transfer of antiviral drugs and the involvement of transporters at the placental barrier[J]. Journal of Pharmaceutical Sciences, 2011, 100(9): 3708-3718. doi: 10.1002/jps.22642
    [15]
    纪淑敏. 不同浓度罗哌卡因配伍舒芬太尼用于产妇分娩镇痛的临床效果观察[J]. 中国计划生育学杂志, 2017, 25(5): 323-327. https://www.cnki.com.cn/Article/CJFDTOTAL-JHSY201705008.htm
    [16]
    阮霞, 李爱媛, 陈锋, 等. 罗哌卡因复合舒芬太尼在潜伏期分娩镇痛中的应用效果[J]. 现代生物医学进展, 2017, 17(7): 1266-1269. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201707017.htm
    [17]
    王汉和, 蒋旻珈, 廖万东, 等. 舒芬太尼联合不同浓度罗哌卡因分娩镇痛对母体影响的研究[J]. 海南医学院学报, 2016, 22(23): 2921-2924. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYY201623037.htm
    [18]
    宋阳, 高扬, 张祎明, 等. 腰麻差异量盐酸罗哌卡因分娩镇痛与导乐仪镇痛的临床对比研究[J]. 河北医学, 2018, 24(12): 2086-2090. doi: 10.3969/j.issn.1006-6233.2018.12.038
    [19]
    宗银东, 聂颖, 姜义铁, 等. 罗哌卡因硬膜外患者自控镇痛的无痛分娩效果及应激反应的临床研究[J]. 重庆医学, 2016, 45(17): 2407-2409. https://www.cnki.com.cn/Article/CJFDTOTAL-CQYX201617038.htm
    [20]
    赵怀金, 郭兴彩. 不同剂量罗哌卡因复合芬太尼硬膜外麻醉对产妇分娩中疼痛症状和母婴结局的影响[J]. 中国医药导刊, 2015, 17(9): 924-925. doi: 10.3969/j.issn.1009-0959.2015.09.031
  • Related Articles

    [1]YANG Hui, XIONG Yuan, CHENG Long, QIAN Ming, JI Li. Mechanism of Dengzhan Shengmai capsule in treating coronary heart disease based on network pharmacology and molecular docking technology[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 1-8, 14. DOI: 10.7619/jcmp.20240541
    [2]GAO Yin, ZHANG Lihong, ZHANG Zhibin, HU Xichi. Mechanism on antibacterial effect in vitro and biofilm eradication effect of Xiaochaihu Decoction and imipenem-cilastatin for carbapenem-resistant Acinetobacter baumannii[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 72-77. DOI: 10.7619/jcmp.20220063
    [3]LI Wenji, HU Fang, XU Wei. Mechanism of Chuanlong Anti-cancer Decoction in treatment of prostate cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 18-23. DOI: 10.7619/jcmp.20214121
    [4]JIN Xuening, LIN Fei, FENG Xinyi, LI Cen, CUI Shu′na. Mechanism of docetaxel in treatment of choriocarcinoma based on network pharmacology[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 18-21. DOI: 10.7619/jcmp.20213494
    [5]QIN Wei, YIN Zixin, HUA Weiwei, WANG Yujie, WANG Yang, DENG Jialin, CAI Zhaoying, QIAN Yayun. Mechanisms of Marsdenia tenacissima in inhibiting gastric cancer based on network pharmacologyand molecular docking technology[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 1-7,17. DOI: 10.7619/jcmp.20213297
    [6]YANG Mei, Dilimeiheri·DILIXIATI, ZHAO Feicui. Anti-ovarian cancer mechanism of processed products of Aconitum soongaricum Stapf. based on network pharmacology[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 1-9. DOI: 10.7619/jcmp.20213376
    [7]CHEN Jiaqi, QIAN Yiming, QIAN Fenghua, Li Jing, LIAN Jiaming, CHEN Xiaotong, LIN Baibai, DING Chunlei. Mechanism of acupuncture in the treatment of acute gastrointestinal injury based on brain-gut peptide[J]. Journal of Clinical Medicine in Practice, 2021, 25(18): 120-123. DOI: 10.7619/jcmp.20211167
    [8]LI Hui, CAO Boya, REN Lutong, WEI Ziying, LI Jiayi, GUO Yuanyuan, WANG Wei, CAO Junling. Exploration on therapeutic mechanisms of Zhishangfeng Granules for common cold based on network pharmacology[J]. Journal of Clinical Medicine in Practice, 2021, 25(12): 18-23, 41. DOI: 10.7619/jcmp.20211607
    [9]LIU Fu-di. Study on the inhibitory effect of antimicrobial peptides-thanatin against staphylococcus aureus[J]. Journal of Clinical Medicine in Practice, 2011, (13): 94-95. DOI: 10.3969/j.issn.1672-2353.2011.13.036
    [10]YE MING, XU Xiu-li, WANG GANG, YANG Xi-min. The analysis of drug resistance phenotype and in vitro antimicrobial agent combination activity against carbapenems -resistant acinetobacter baumannii[J]. Journal of Clinical Medicine in Practice, 2011, (11): 44-46. DOI: 10.3969/j.issn.1672-2353.2011.11.014

Catalog

    Article views (196) PDF downloads (13) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return